2023 Grants and Awards Recipients (funded by Mars Shot)

SNMMI-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Imaging Research Grant- Marina Sharifi, MD, PhD

SNMMI Mars Shot Fund - Amir Iravani, MD 

SNMMI Mars Shot Fund - Julie Sutcliffe, PhD 

SNMMI Mars Shot Fund - Craig Levin, PhD 

SNMMI Mars Shot Fund - Randy Yeh, MD

SNMMI Mars Shot Fund - Paul Ellison, PhD; Peter Scott, PhD; MS Sanford, PhD, and JW Engle, PhD

2023 Grants and Awards Recipients (funded by SNMMI)

Minoshima-Pappas Transformative Leadership Award - Umar Mahmood, MD, FSNMMI

Lalita and Mathew (Madhukar) Thakur Award - Hanwen Zhang, PhD

2023 Grants and Awards Recipients (funded by WINM)

Women in Nuclear Medicine Rising Star Award- Raiyan Zaman, PhD

Women in Nuclear Medicine She Paved the Way Lifetime Achievement Award - Leonie Gordon, MD, FSNMMI

2023 Grants and Awards Recipients (funded by the ERF)

Sam Gambhir, MD Trailblazer Award - Peter Scott, PhD, FSNMMI

Arthur M. Weis, PhD, Award in Radiation Dosimetry and Safety - Kellen Fitzpatrick

Michael J. Welch Award - Sally Schwarz, MS, RPh, BCNP, FAPhA

Michael J. Welch Postdoctoral Grant - Xuedan Wu, PhD

Mitzi & William Blahd, MD, Pilot Research Grant - Israt Alam, PhD

Robert E. Henkin, MD, Government Relations Fellowship - Angellica O. Gordon, MD

Ursula Mary-Kocemba Slosky, PhD, Professional Relations Fellowship - Bhasker Radaram, PhD and Remo George, PhD

ERF SNMMI Molecular Imaging Research Grant for Junior Academic Faculty - Remco Bastiaannet, PhD

ERF SNMMI Postdoctoral Molecular Imaging Scholar Program - n/a 2023

SNMMI CMIIT Laboratory Professional Recognition Award for Contributions to Molecular Imaging - Freda Crawford, CNMT

Bradley-Alavi Student Fellowships: Roberto Fedrigo, Peter Park, and Zitong Yu

Paul C. Aebersold, PhD Award - Henry VanBrocklin, PhD, FSNMMI

The Sipra and Gopal Saha Scholarship - Ahmed Abdelrahman, MD 

2023 Alavi-Mandell Awards Published in 2022 - 

Choice Is Good at Times: The Emergence of [⁶⁴Cu]Cu-DOTATATE–Based Somatostatin Receptor Imaging in the Era of [⁶⁸Ga]Ga-DOTATATE

Abhishek Jha, Mayank Patel, Jorge A. Carrasquillo, Clara C. Chen, Corina Millo, Roberto Maass-Moreno, Alexander Ling, Frank I. Lin, Ronald M. Lechan, Thomas A. Hope, David Taïeb, Ali Cahid Civelek, and Karel Pacak

National Institutes of Health, Bethesda, Maryland

J Nucl Med 2022; 63:1300–1301

Combined PARP1-Targeted Nuclear Contrast and Reflectance Contrast Enhance Confocal Microscopic Detection of Basal Cell Carcinoma

Aditi Sahu, Jose Cordero, Xiancheng Wu, Susanne Kossatz, Ucalene Harris, Paula Demetrio Desouza Franca, Nicholas R. Kurtansky, Niasia Everett, Stephen Dusza, Jilliana Monnier, Piyush Kumar, Christi Fox, Christian Brand, Sheryl Roberts, Kivanc Kose, William Phillips, Erica Lee, Chih-Shan Jason Chen, Anthony Rossi, Kishwer Nehal, Melissa Pulitzer, Caterina Longo, Allan Halpern, Thomas Reiner, Milind Rajadhyaksha, and Manu Jain

Dermatology Service, MSKCC, New York, New York

J Nucl Med 2022; 63:912–918

Combination of Carriers with Complementary Intratumoral Microdistributions of Delivered α-Particles May Realize the Promise for ²²⁵Ac in Large, Solid Tumors

Alaina Howe, Omkar Bhatavdekar, Dominick Salerno, Anders Josefsson, Jesus Pacheco-Torres, Zaver M. Bhujwalla, Kathleen L. Gabrielson, George Sgouros, and Stavroula Sofou

Chemical and Biomolecular Engineering, Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, Maryland

J Nucl Med 2022; 63:1223–1230

Synthesis and Preclinical Evaluation of ¹⁷⁷Lu-Labeled Radiohybrid PSMA Ligands for Endoradiotherapy of Prostate Cancer

Alexander Wurzer, Jan-Philip Kunert, Sebastian Fischer, Veronika Felber, Roswitha Beck, Francesco de Rose, Calogero D’Alessandria, Wolfgang Weber, and Hans-Jürgen Wester

Chair of Pharmaceutical Radiochemistry, Technical University of Munich, Garching, Germany

J Nucl Med 2022; 63:1489–1495

Optimizing Immuno-PET Imaging of Tumor PD-L1 Expression: Pharmacokinetic, Biodistribution, and Dosimetric Comparisons of ⁸⁹Zr-Labeled Anti-PD-L1 Antibody Formats

Alizée Bouleau, Hervé Nozach, Steven Dubois, Dimitri Kereselidze, Céline Chevaleyre, Cheng-I Wang, Michael J. Evans, Vincent Lebon, Bernard Maillère, and Charles Truillet

Paris-Saclay University, CEA, CNRS, INSERM, Multimodal Biomedical Imaging Lab, Orsay, France

J Nucl Med 2022; 63:1259–1265

A Comparison of ¹⁸F-DCFPyL, ¹⁸F-NaF, and ¹⁸F-FDG PET/CT in a Prospective Cohort of Men with Metastatic Prostate Cancer

Aloÿse Fourquet, Adrian Rosenberg, Esther Mena, Joanna J. Shih, Baris Turkbey, Maxime Blain, Ethan Bergvall, Frank Lin, Stephen Adler, Ilhan Lim, Ravi A. Madan, Fatima Karzai, James L. Gulley, William L. Dahut, Bradford J. Wood, Richard Chang, Elliot Levy, Peter L. Choyke, and Liza Lindenberg

Molecular Imaging Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland

J Nucl Med 2022; 63:735–741

A Dimeric FAP-Targeting Small-Molecule Radioconjugate with High and Prolonged Tumor Uptake

Andrea Galbiati, Aureliano Zana, Matilde Bocci, Jacopo Millul, Abdullah Elsayed, Jacqueline Mock, Dario Neri, and Samuele Cazzamalli

Research and Development Department, Philochem AG, Otelfingen, Switzerland

J Nucl Med 2022; 63:1852–1858

Advances in Detector Instrumentation for PET

Andrea Gonzalez-Montoro, Muhammad Nasir Ullah, and Craig S. Levin

Department of Radiology, Molecular Imaging Program at Stanford University, Stanford, California

J Nucl Med 2022; 63:1138–1144

Tumor Sink Effect in ⁶⁸Ga-PSMA-11 PET: Myth or Reality?

Andrei Gafita, Hui Wang, Andrew Robertson, Wesley R. Armstrong, Raphael Zaum, Manuel Weber, Farid Yagubbayli, Clemens Kratochwil, Tristan R. Grogan, Kathleen Nguyen, Fernando Navarro, Rouzbeh Esfandiari, Isabel Rauscher, Bjoern Menze, David Elashoff, Ebrahim S. Delpassand, Ken Herrmann, Johannes Czernin, Michael S. Hofman, Jeremie Calais, Wolfgang P. Fendler, and Matthias Eiber

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California

J Nucl Med 2022; 63:226–232

Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study

Andrei Gafita, Isabel Rauscher, Manuel Weber, Boris Hadaschik, Hui Wang, Wesley R. Armstrong, Robert Tauber, Tristan R. Grogan, Johannes Czernin, Matthew B. Rettig, Ken Herrmann, Jeremie Calais, Wolfgang A. Weber, Matthias R. Benz, Wolfgang P. Fendler, and Matthias Eiber

Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California

J Nucl Med 2022; 63:1651–1658

CD133 as a Biomarker for an Autoantibody-to-ImmunoPET Paradigm for the Early Detection of Small Cell Lung Cancer

Andrew G. Kunihiro, Samantha M. Sarrett, Kristin J. Lastwika, Joell L. Solan, Tatyana Pisarenko, Outi Keinänen, Cindy Rodriguez, Lydia R. Taverne, Annette L. Fitzpatrick, Christopher I. Li, A. McGarry Houghton, Brian M. Zeglis, and Paul D. Lampe

Translational Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington

J Nucl Med 2022; 63:1701–1707

Evolution of ¹⁸F-FDG PET/CT Findings in Patients After COVID-19: An Initial Investigation

Andrew Thornton, Francesco Fraioli, Simon Wan, Helen S. Garthwaite, Balaji Ganeshan, Robert I. Shortman, Raymond Endozo, Stefan Vöö, Irfan Kayani, Deena Neriman, Leon Menezes, Jamshed Bomanji, Toby Hilllman, Melissa Heightman, Joanna C. Porter, and Ashley M. Groves

Institute of Nuclear Medicine, UCLH/UCL, London, United Kingdom

J Nucl Med 2022; 63:270–273

Study of ⁸⁹Zr-Pembrolizumab PET/CT in Patients With Advanced-Stage Non–Small Cell Lung Cancer

Anna-Larissa N. Niemeijer, Daniela E. Oprea-Lager, Marc C. Huisman, Otto S. Hoekstra, Ronald Boellaard, Berlinda J. de Wit-van der Veen, Idris Bahce, Daniëlle J. Vugts, Guus A.M.S. van Dongen, Erik Thunnissen, Egbert F. Smit, and Adrianus J. de Langen

Department of Pulmonary Diseases, Cancer Center Amsterdam, Amsterdam University Medical Centers, Amsterdam, The Netherlands

J Nucl Med 2022; 63:362–367

Toward a Patient-Specific Traceable Quantification of SPECT/CT-Based Radiopharmaceutical Distributions

Anna-Lena Theisen, Michael Lassmann, and Johannes Tran-Gia

Department of Nuclear Medicine, University of Würzburg, Würzburg, Germany

J Nucl Med 2022; 621108–1116

Experience with a Perfusion-Only Screening Protocol for Evaluation of Pulmonary Embolism During the COVID-19 Pandemic Surge

Arun Kumar, Renée M. Moadel, Linda B. Haramati, Kenny Ye, Leonard M. Freeman, and Lionel S. Zuckier

Division of Nuclear Medicine, Montefiore Medical Center and Albert Einstein College of Medicine, Bronx, New York

J Nucl Med 2022; 63:598–601

Detection of Additional Primary Neoplasms on ¹⁸F-Fluciclovine PET/CT in Patients with Primary Prostate Cancer

Ashwin Singh Parihar, Lisa R. Schmidt, Farrokh Dehdashti, and Richard L. Wahl

Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, Missouri

J Nucl Med 2022; 63:713–719

Pretherapeutic Comparative Dosimetry of ¹⁷⁷Lu-rhPSMA-7.3 and ¹⁷⁷Lu-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer

Benedikt Feuerecker, Maythinee Chantadisai, Anne Allmann, Robert Tauber, Jakob Allmann, Lisa Steinhelfer, Isabel Rauscher, Alexander Wurzer, Hans-Jürgen Wester, Wolfgang A. Weber, Calogero d’Alessandria, and Matthias Eiber

Department of Nuclear Medicine, School of Medicine, Technical University of Munich, München, Germany

J Nucl Med 2022; 63:833–839

Cyclooxygenases as Potential PET Imaging Biomarkers to Explore Neuroinflammation in Dementia

Bruny V. Kenou, Lester S. Manly, Sara B. Rubovits, Somachukwu A. Umeozulu, Maia G. Van Buskirk, Andrea S. Zhang, Victor W. Pike, Paolo Zanotti-Fregonara, Ioline D. Henter, and Robert B. Innis

Molecular Imaging Branch, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland

J Nucl Med 2022; 63(suppl 1):53S–59S

First In Vivo and Phantom Imaging of Cyclotron-Produced ¹³³La as a Theranostic Radionuclide for ²²⁵Ac and ¹³⁵La

Bryce J.B. Nelson, Simon Ferguson, Melinda Wuest, John Wilson, M. John M. Duke, Susan Richter, Hans Soenke-Jans, Jan D. Andersson, Freimut Juengling, and Frank Wuest

Department of Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Alberta, Canada

J Nucl Med 2022; 63:584–590

Comparison of ¹¹C-Pittsburgh Compound B and ¹⁸F-Flutemetamol White Matter Binding in PET

Burcu Zeydan, Christopher G. Schwarz, Scott A. Przybelski, Timothy G. Lesnick, Walter K. Kremers, Matthew L. Senjem, Orhun H. Kantarci, Paul H. Min, Bradley J. Kemp, Clifford R. Jack, Kejal Kantarci, and Val J. Lowe

Department of Radiology, Mayo Clinic, Rochester, Minnesota

J Nucl Med 2022; 63:1239–1244

Striatal Acetylcholine–Dopamine Imbalance in Parkinson Disease: In Vivo Neuroimaging Study with Dual-Tracer PET and Dopaminergic PET–Informed Correlational Tractography

Carlos A. Sanchez-Catasus, Nicolaas I. Bohnen, Nicholas D’Cruz, and Martijn L.T.M. Müller

Division of Nuclear Medicine, Department of Radiology, University of Michigan Health System, Ann Arbor, Michigan

J Nucl Med 2022; 63:438–445

Longitudinal Imaging of T Cells and Inflammatory Demyelination in a Preclinical Model of Multiple Sclerosis Using ¹⁸F-FAraG PET and MRI

Caroline Guglielmetti, Jelena Levi, Tony L. Huynh, Brice Tiret, Joseph Blecha, Ryan Tang, Henry VanBrocklin, and Myriam M. Chaumeil

Department of Physical Therapy and Rehabilitation Science, University of California, San Francisco, San Francisco, California

J Nucl Med 2022; 63:140–146

PET Tracing of Biodistribution for Orally Administered ⁶⁴Cu-Labeled Polystyrene in Mice

Changkeun Im, Hyeongi Kim, Javeria Zaheer, Jung Young Kim, Yong-Jin Lee, Choong Mo Kang, and Jin Su Kim

Division of Applied RI, Korea Institute of Radiological and Medical Sciences, Seoul, Korea

J Nucl Med 2022; 63:461–467

Using ⁶⁸Ga-PSMA-11 PET/CT for Therapy Response Assessment in Patients with Metastatic Castration-Resistant Prostate Cancer: Application of EAU/EANM Recommendations in Clinical Practice

Chloé S. Denis, François Cousin, Bram De Laere, Roland Hustinx, Brieuc R. Sautois, and Nadia Withofs

Medical Oncology Department, University Hospital of Liège, Liège, Belgium

J Nucl Med 2022; 63:1815–1821

Prevalence and Outcomes of Cardiac Amyloidosis in All-Comer Referrals for Bone Scintigraphy

Christian Nitsche, Katharina Mascherbauer, Raffaella Calabretta, Matthias Koschutnik, Carolina Dona, Varius Dannenberg, Felix Hofer, Kseniya Halavina, Andreas A. Kammerlander, Tatjana Traub-Weidinger, Georg Goliasch, Christian Hengstenberg, Marcus Hacker, and Julia Mascherbauer

Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria

J Nucl Med 2022; 63:1906–1911

Antibody Engineering for Nuclear Imaging and Radioimmunotherapy

Cindy Rodriguez, Samantha Delaney, Samantha M. Sarrett, Outi M. Keinänen, and Brian M. Zeglis

Department of Chemistry, Hunter College, City University of New York, New York, New York

J Nucl Med 2022; 63:1316–1322

 

Enhancing ²²³Ra Treatment Efficacy by Anti-β1 Integrin Targeting

Claudia Paindelli, Stefano Casarin, Feng Wang, Luis Diaz-Gomez, Jianhua Zhang, Antonios G. Mikos, Christopher J. Logothetis, Peter Friedl, and Eleonora Dondossola

Department of Genitourinary Medical Oncology and David H. Koch Center for Applied Research of Genitourinary Cancers, University of Texas M.D. Anderson Cancer Center, Houston, Texas

J Nucl Med 2022; 63:1039–1045

¹⁸F-FDG PET Improves Baseline Clinical Predictors of Response in Diffuse Large B-Cell Lymphoma: The HOVON-84 Study

Coreline N. Burggraaff, Jakoba J. Eertink, Pieternella J. Lugtenburg, Otto S. Hoekstra, Anne I.J. Arens, Bart de Keizer, Martijn W. Heymans, Bronno van der Holt, Sanne E. Wiegers, Simone Pieplenbosch, Ronald Boellaard, Henrica C.W. de Vet, and Josée M. Zijlstra, on behalf of the HOVON Imaging Working Group and the HOVON Lymphoma Working Group

Department of Hematology, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands

J Nucl Med 2022; 63:1001–1007

 

A Longitudinal PET/MRI Study of Colony-Stimulating Factor 1 Receptor–Mediated Microglia Depletion in Experimental Stroke

Cristina Barca, Amanda J. Kiliaan, Claudia Foray, Lydia Wachsmuth, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Andreas H. Jacobs, and Bastian Zinnhardt

European Institute for Molecular Imaging, University of Münster, Münster, Germany

J Nucl Med 2022; 63:446–452

 

Short-Term Colony-Stimulating Factor 1 Receptor Inhibition–Induced Repopulation After Stroke Assessed by Longitudinal ¹⁸F-DPA-714 PET Imaging

Cristina Barca, Amanda J. Kiliaan, Lydia Wachsmuth, Claudia Foray, Sven Hermann, Cornelius Faber, Michael Schäfers, Maximilian Wiesmann, Bastian Zinnhardt, and Andreas H. Jacobs

European Institute for Molecular Imaging, University of Münster, Münster, Germany

J Nucl Med 2022; 63:1408–1414

 

Incidental Findings Suggestive of COVID-19 Pneumonia in Oncologic Patients Undergoing ¹⁸F-FDG PET/CT Studies: Association Between Metabolic and Structural Lung Changes

Cristina Gamila Wakfie-Corieh, Federico Ferrando-Castagnetto, Alba María Blanes García, Marta García García-Esquinas, Aída Ortega Candil, Cristina Rodríguez Rey, María Nieves Cabrera-Martín, Ana Delgado Cano, and José Luis Carreras Delgado

Department of Nuclear Medicine, Hospital Clínico San Carlos, Madrid, Spain

J Nucl Med 2022; 63:274–279

 

Dosimetric Quantities in Neuroendocrine Tumors over Treatment Cycles with ¹⁷⁷Lu-DOTATATE

Daniel Roth, Johan Gustafsson, Carl Fredrik Warfvinge, Anna Sundlöv, Anna Åkesson, Jan Tennvall, and Katarina Sjögreen Gleisner

Department of Medical Radiation Physics, Clinical Sciences Lund, Lund University, Lund, Sweden

J Nucl Med 2022; 63:399–405

 

Impact of ComBat Harmonization on PET Radiomics-Based Tissue Classification: A Dual-Center PET/MRI and PET/CT Study

Doris Leithner, Heiko Schöder, Alexander Haug, H. Alberto Vargas, Peter Gibbs, Ida Häggström, Ivo Rausch, Michael Weber, Anton S. Becker, Jazmin Schwartz, and Marius E. Mayerhoefer

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2022; 63:1611–1616

 

Efficient Delay Correction for Total-Body PET Kinetic Modeling Using Pulse Timing Methods

Elizabeth J. Li, Benjamin A. Spencer, Jeffrey P. Schmall, Yasser Abdelhafez, Ramsey D. Badawi, Guobao Wang, and Simon R. Cherry

Department of Biomedical Engineering, University of California Davis, Davis, California

J Nucl Med 2022; 63:1266–1273

 

Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders

Elon D. Wallert, Elsmarieke van de Giessen, Remco J.J. Knol, Martijn Beudel, Rob M.A. de Bie, and Jan Booij

Department of Radiology and Nuclear Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands

J Nucl Med 2022; 63(suppl 1):27S–32S

 

¹⁸F-DOPA PET/CT at the Forefront of Initial or Presurgical Evaluation of Small-Intestine Neuroendocrine Tumors

Eric Ouvrard, Louis De Mestier, Caroline Boursier, Boumediene Lachachi, Nicolas Sahakian, Elodie Chevalier, Nidaa Mikail, Josefina Carullo, Aurélie Bando-Delaunay, Thomas Walter, Gabriel G. Malouf, Pietro Addeo, Gilles Poncet, Frederic Sebag, Rachida Lebtahi, Bernard Goichot, David Taïeb, and Alessio Imperiale

Nuclear Medicine and Molecular Imaging, Institut de Cancérologie Strasbourg Europe, University Hospitals of Strasbourg, University of Strasbourg, Strasbourg, France

J Nucl Med 2022; 63:1865–1870

Prospective Phase II Trial of Prognostication by ⁶⁸Ga-NOTA-AE105 uPAR PET in Patients with Neuroendocrine Neoplasms: Implications for uPAR-Targeted Therapy

Esben Andreas Carlsen, Mathias Loft, Annika Loft, Anne Kiil Berthelsen, Seppo W. Langer, Ulrich Knigge, and Andreas Kjaer

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital – Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

J Nucl Med 2022; 63:1371–1377

 

Latest Advances in Multimodality Imaging of Aortic Stenosis

Evangelos Tzolos, Jacek Kwiecinski, Daniel Berman, Piotr Slomka, David E. Newby, and Marc R. Dweck

British Heart Foundation Centre for Cardiovascular Science, University of Edinburgh, Edinburgh, United Kingdom

J Nucl Med 2022; 63:353–358

 

Dynamic Amyloid PET: Relationships to ¹⁸F-Flortaucipir Tau PET Measures

Fabio Raman, Yu-Hua Dean Fang, Sameera Grandhi, Charles F. Murchison, Richard E. Kennedy, John C. Morris, Parinaz Massoumzadeh, Tammie Benzinger, Erik D. Roberson, and Jonathan McConathy

Department of Radiology, University of Alabama at Birmingham, Birmingham, Alabama

J Nucl Med 2022; 63:287–293

 

Precision Surgery Guided by Intraoperative Molecular Imaging

Feredun Azari, Kevin Zhang, Gregory T. Kennedy, Ashley Chang, Bilal Nadeem, Edward J. Delikatny, and Sunil Singhal

Department of Thoracic Surgery, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania

J Nucl Med 2022; 63:1620–1627

 

Repetitive Early ⁶⁸Ga-FAPI PET Acquisition Comparing ⁶⁸Ga-FAPI-02, ⁶⁸Ga-FAPI-46, and ⁶⁸Ga-FAPI-74: Methodologic and Diagnostic Implications for Malignant, Inflammatory/Reactive, and Degenerative Lesions

Frederik M. Glatting, Jorge Hoppner, Dawn P. Liew, Antonia van Genabith, Anna-Maria Spektor, Levin Steinbach, Alexander Hubert, Clemens Kratochwil, Frederik L. Giesel, Katharina Dendl, Hendrik Rathke, Hans-Ulrich Kauczor, Peter E. Huber, Uwe Haberkorn, and Manuel Röhrich

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany

J Nucl Med 2022; 63:1844–1851

 

Fluorescent Molecular Imaging Can Improve Intraoperative Sentinel Margin Detection in Oral Squamous Cell Carcinoma

Giri Krishnan, Nynke S. van den Berg, Naoki Nishio, Shrey Kapoor, Jaqueline Pei, Laura Freeman, Yu-Jin Lee, Quan Zhou, Stan van Keulen, Shayan Farkurnejad, James Condon, Fred M. Baik, Brock A. Martin, and Eben L. Rosenthal

Department of Otolaryngology–Head and Neck Surgery, Stanford University School of Medicine, Stanford, California

J Nucl Med 2022; 63:1162–1168

 

Dosimetric Evaluation of the Effect of Receptor Heterogeneity on the Therapeutic Efficacy of Peptide Receptor Radionuclide Therapy: Correlation with DNA Damage Induction and In Vivo Survival

Giulia Tamborino, Julie Nonnekens, Marijke De Saint-Hubert, Lara Struelens, Danny Feijtel, Marion de Jong, and Mark W. Konijnenberg

Research in Dosimetric Application, Belgian Nuclear Research Centre, Mol, Belgium

J Nucl Med 2022; 63:100–107

 

Modeling Early Radiation DNA Damage Occurring During ¹⁷⁷Lu-DOTATATE Radionuclide Therapy

Giulia Tamborino, Yann Perrot, Marijke De Saint-Hubert, Lara Struelens, Julie Nonnekens, Marion De Jong, Mark W. Konijnenberg, and Carmen Villagrasa

Research in Dosimetric Applications, Belgian Nuclear Research Centre, Mol, Belgium

J Nucl Med 2022; 63:761–769

 

Glitter in the Darkness? Nonfibrillar β-Amyloid Plaque Components Significantly Impact the β-Amyloid PET Signal in Mouse Models of Alzheimer Disease

Gloria Biechele, Laura Sebastian Monasor, Karin Wind, Tanja Blume, Samira Parhizkar, Thomas Arzberger, Christian Sacher, Leonie Beyer, Florian Eckenweber, Franz-Josef Gildehaus, Barbara von Ungern-Sternberg, Michael Willem, Peter Bartenstein, Paul Cumming, Axel Rominger, Jochen Herms, Stefan F. Lichtenthaler, Christian Haass, Sabina Tahirovic, and Matthias Brendel

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany

J Nucl Med 2022; 63:117–124

 

Effects of Tracer Uptake Time in Non–Small Cell Lung Cancer ¹⁸F-FDG PET Radiomics

Guilherme D. Kolinger, David Vállez García, Gerbrand Maria Kramer, Virginie Frings, Gerben J.C. Zwezerijnen, Egbert F. Smit, Adrianus Johannes de Langen, Irène Buvat, and Ronald Boellaard

Medical Imaging Center, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

J Nucl Med 2022; 63:919–924

 

¹⁸F-FDG PET/CT–Based Prognostic Survival Model After Surgery for Head and Neck Cancer

Gwenaelle Creff, Franck Jegoux, Xavier Palard, Adrien Depeursinge, Ronan Abgral, Remi Marianowski, Jean-Christophe Leclere, Thomas Eugene, Olivier Malard, Renaud De Crevoisier, Anne Devillers, and Joel Castelli

Department of Otolaryngology–Head and Neck Surgery (HNS), University Hospital, Rennes, France

J Nucl Med 2022; 63:1378–1385

 

Evaluation of Deep Learning–Based Approaches to Segment Bowel Air Pockets and Generate Pelvic Attenuation Maps from CAIPIRINHA-Accelerated Dixon MR Images

Hasan Sari, Ja Reaungamornrat, Onofrio A. Catalano, Javier Vera-Olmos, David Izquierdo-Garcia, Manuel A. Morales, Angel Torrado-Carvajal, Thomas S.C. Ng, Norberto Malpica, Ali Kamen, and Ciprian Catana

Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital and Harvard Medical School, Charlestown, Massachusetts

J Nucl Med 2022; 63:468–475

 

Correlation of ⁶⁸Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer

Heying Duan, Lucia Baratto, Richard E. Fan, Simon John Christoph Soerensen, Tie Liang, Benjamin Inbeh Chung, Alan Eih Chih Thong, Harcharan Gill, Christian Kunder, Tanya Stoyanova, Mirabela Rusu, Andreas M. Loening, Pejman Ghanouni, Guido A. Davidzon, Farshad Moradi, Geoffrey A. Sonn, and Andrei Iagaru

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California

J Nucl Med 2022; 63:1829–1835

 

c-MET Receptor–Targeted Fluorescence on the Road to Image-Guided Surgery in Penile Squamous Cell Carcinoma Patients

Hielke M. de Vries, Elise Bekers, Matthias N. van Oosterom, M. Baris Karakullukcu, Henk G. van, der Poel, Fijs W.B. van Leeuwen, Tessa Buckle, and Oscar R. Brouwer

Department of Urology, Netherlands Cancer Institute, Amsterdam, The Netherlands

J Nucl Med 2022; 63:51–56

 

Comparing Semiquantitative and Qualitative Methods of Vascular ¹⁸F-FDG PET Activity Measurement in Large-Vessel Vasculitis

Himanshu R. Dashora, Joel S. Rosenblum, Kaitlin A. Quinn, Hugh Alessi, Elaine Novakovich, Babak Saboury, Mark A. Ahlman, and Peter C. Grayson

Systemic Autoimmunity Branch, NIAMS, National Institutes of Health, Bethesda, Maryland

J Nucl Med 2022; 63:280–286

¹⁸F-DCFPyL PET Acquisition, Interpretation, and Reporting: Suggestions After Food and Drug Administration Approval

Hong Song, Andrei Iagaru, and Steven P. Rowe

Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Stanford University, Stanford, California

J Nucl Med 2022; 63:855–859

 

Antiandrogen Therapy Radiosensitizes Androgen Receptor–Positive Cancers to ¹⁸F-FDG

Indulekha Singaravelu, Henry Spitz, Mary Mahoney, Zhongyun Dong, and Nalinikanth Kotagiri

Division of Pharmaceutical Sciences, James L. Winkle College of Pharmacy, University of Cincinnati, Cincinnati, Ohio

J Nucl Med 2022; 63:1177–1183

 

A Radiotracer for Molecular Imaging and Therapy of Gastrin-Releasing Peptide Receptor–Positive Prostate Cancer

Ivica J. Bratanovic, Chengcheng Zhang, Zhengxing Zhang, Hsiou‐Ting Kuo, Nadine Colpo, Jutta Zeisler, Helen Merkens, Carlos Uribe, Kuo‐Shyan Lin, and François Bénard

BC Cancer, Vancouver, British Columbia, Canada

J Nucl Med 2022; 63:424–430

 

Machine Learning with ¹⁸F-Sodium Fluoride PET and Quantitative Plaque Analysis on CT Angiography for the Future Risk of Myocardial Infarction

Jacek Kwiecinski, Evangelos Tzolos, Mohammed N. Meah, Sebastien Cadet, Philip D. Adamson, Kajetan Grodecki, Nikhil V. Joshi, Alastair J. Moss, Michelle C. Williams, Edwin J.R. van Beek, Daniel S. Berman, David E. Newby, Damini Dey, Marc R. Dweck, and Piotr J. Slomka

Division of Artificial Intelligence in Medicine, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California

J Nucl Med 2022; 63:158–165

 

Quantitative Radiomics Features in Diffuse Large B-Cell Lymphoma: Does Segmentation Method Matter?

Jakoba J. Eertink, Elisabeth A.G. Pfaehler, Sanne E. Wiegers, Tim van, de Brug, Pieternella J. Lugtenburg, Otto S. Hoekstra, Josée M. Zijlstra, Henrica C.W. de Vet, and Ronald Boellaard

Department of Hematology, Amsterdam UMC, Vrije Universiteit Amsterdam, Cancer Center Amsterdam, Amsterdam, The Netherlands

J Nucl Med 2022; 63:389–395

 

Epidermal Growth Factor Receptor–Targeted Fluorescence Molecular Imaging for Postoperative Lymph Node Assessment in Patients with Oral Cancer

Jasper Vonk, Jaron G. de Wit, Floris J. Voskuil, Yang Hang Tang, Wouter T.R. Hooghiemstra, Matthijs D. Linssen, Evert van den Broek, Jan J. Doff, Sebastiaan A.H.J. de Visscher, Kees-Pieter Schepman, Bert van der Vegt, Gooitzen M. van Dam, and Max J.H. Witjes

Department of Oral and Maxillofacial Surgery, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

J Nucl Med 2022; 63:672–678

 

Relative Strengths of Three Linearizations of Receptor Availability: Saturation, Inhibition, and Occupancy Plots

Javad Khodaii, Mostafa Araj-Khodaei, Manouchehr S. Vafaee, Dean F. Wong, and Albert Gjedde

Department of Mechanical Engineering, Amirkabir University of Technology, Tehran, Iran

J Nucl Med 2022; 63:294–301

 

Signaling Pathways That Drive ¹⁸F-FDG Accumulation in Cancer

Jessica R. Salas and Peter M. Clark

Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California

J Nucl Med 2022; 63:659–663

 

The Overlap Index as a Means of Evaluating Early Tau PET Signal Reliability

Jeyeon Lee, Brian J. Burkett, Hoon-Ki Min, Emily S. Lundt, Sabrina M. Albertson, Hugo Botha, Matthew L. Senjem, Jeffrey L. Gunter, Christopher G. Schwarz, David T. Jones, David S. Knopman, Clifford R. Jack, Ronald C. Petersen, and Val J. Lowe

Department of Radiology, Rochester, Minnesota

J Nucl Med 2022; 63:1748–1753

 

Functional Characterization of Adrenocortical Masses in Nononcologic Patients Using ⁶⁸Ga-Pentixafor

Jie Ding, Anli Tong, Yushi Zhang, Jin Wen, Hui Zhang, Marcus Hacker, Li Huo, and Xiang Li

Department of Nuclear Medicine, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine and State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

J Nucl Med 2022; 63:368–375

 

Long-Term Outcomes of Transarterial Radioembolization for Large Single Hepatocellular Carcinoma: A Comparison to Resection

Jihye Kim, Ju Yeon Kim, Jeong-Hoon Lee, Dong Hyun Sinn, Moon Haeng Hur, Ji Hoon Hong, Min Kyung Park, Hee Jin Cho, Na Ryung Choi, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Yoon Jun Kim, Jin Chul Paeng, Hyo Cheol Kim, Nam-Joon Yi, Kwang-Woong Lee, Kyung-Suk Suh, Dongho Hyun, Jong Man Kim, and Jung-Hwan Yoon

Department of Internal Medicine and Liver Research Institute, Seoul National University College of Medicine, Seoul, Korea

J Nucl Med 2022; 63:1215–1222

 

Predicting the Outcome of Epilepsy Surgery by Covariance Pattern Analysis of Ictal Perfusion SPECT

Jila Taherpour, Mariam Jaber, Berthold Voges, Ivayla Apostolova, Thomas Sauvigny, Patrick M. House, Michael Lanz, Matthias Lindenau, Susanne Klutmann, Tobias Martens, Stefan Stodieck, and Ralph Buchert

Department of Diagnostic and Interventional Radiology and Nuclear Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany

J Nucl Med 2022; 63:925–930

 

Cardiac Fibroblast Activation in Patients Early After Acute Myocardial Infarction: Integration with MR Tissue Characterization and Subsequent Functional Outcome

Johanna Diekmann, Tobias Koenig, James T. Thackeray, Thorsten Derlin, Christoph Czerner, Jonas Neuser, Tobias L. Ross, Andreas Schäfer, Jochen Tillmanns, Johann Bauersachs, and Frank M. Bengel

Department of Nuclear Medicine, Hannover Medical School, Hannover, Germany

J Nucl Med 2022; 63:1415–1423

 

Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 1: Technical Considerations and Perfusion and Neuronal Imaging

John C. Stendahl, Jennifer M. Kwan, Darko Pucar, and Mehran M. Sadeghi

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut

J Nucl Med 2022; 63:649–658

 

Radiotracers to Address Unmet Clinical Needs in Cardiovascular Imaging, Part 2: Inflammation, Fibrosis, Thrombosis, Calcification, and Amyloidosis Imaging

John C. Stendahl, Jennifer M. Kwan, Darko Pucar, and Mehran M. Sadeghi

Section of Cardiovascular Medicine, Yale University School of Medicine, New Haven, Connecticut

J Nucl Med 2022; 63:986–994

Molecular Imaging of Neuroendocrine Prostate Cancer by Targeting Delta-Like Ligand 3

Joshua A. Korsen, Teja M. Kalidindi, Samantha Khitrov, Zachary V. Samuels, Goutam Chakraborty, Julia A. Gutierrez, John T. Poirier, Charles M. Rudin, Yu Chen, Michael J. Morris, Nagavarakishore Pillarsetty, and Jason S. Lewis

Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2022; 63:1401–1407

 

Cerenkov Luminescence Imaging in Prostate Cancer: Not the Only Light That Shines

Judith olde Heuvel, Berlinda J. de Wit-van der Veen, Henk G. van der Poel, Pim J. van Leeuwen, Elise M. Bekers, Maarten R. Grootendorst, Kunal N. Vyas, Cornelis H. Slump, and Marcel P.M. Stokkel

Department of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands

J Nucl Med 2022; 63:29–35

 

The Impact of Semiautomatic Segmentation Methods on Metabolic Tumor Volume, Intensity, and Dissemination Radiomics in ¹⁸F-FDG PET Scans of Patients with Classical Hodgkin Lymphoma

Julia Driessen, Gerben J.C. Zwezerijnen, Heiko Schöder, Esther E.E. Drees, Marie José Kersten, Alison J. Moskowitz, Craig H. Moskowitz, Jakoba J. Eertink, Henrica C.W. de Vet, Otto S. Hoekstra, Josée M. Zijlstra, and Ronald Boellaard

Department of Hematology, Amsterdam UMC, University of Amsterdam, LYMMCARE (Lymphoma and Myeloma Center, Amsterdam), Cancer Center Amsterdam, Amsterdam, The Netherlands

J Nucl Med 2022; 63:1424–1430

 

Cost Effectiveness of ¹⁸F-FET PET for Early Treatment Response Assessment in Glioma Patients After Adjuvant Temozolomide Chemotherapy

Jurij Rosen, Garry Ceccon, Elena K. Bauer, Jan-Michael Werner, Caroline Tscherpel, Veronika Dunkl, Marion Rapp, Michael Sabel, Ulrich Herrlinger, Alexander Heinzel, Niklas Schäfer, Maximilian Ruge, Roland Goldbrunner, Gabriele Stoffels, Christoph Kabbasch, Gereon R. Fink, Karl-Josef Langen, and Norbert Galldiks

Department of Neurology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany

J Nucl Med 2022; 63:1677–1682

 

Initial Clinical Experience with ⁹⁰Y-FAPI-46 Radioligand Therapy for Advanced-Stage Solid Tumors: A Case Series of 9 Patients

Justin Ferdinandus, Pedro Fragoso Costa, Lukas Kessler, Manuel Weber, Nader Hirmas, Karina Kostbade, Sebastian Bauer, Martin Schuler, Marit Ahrens, Hans-Ulrich Schildhaus, Christoph Rischpler, Hong Grafe, Jens T. Siveke, Ken Herrmann, Wolfgang P. Fendler, and Rainer Hamacher

Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, University of Duisburg-Essen, Essen, Germany, and Uital Essen, Essen, Germany

J Nucl Med 2022; 63:727–734

 

PSMA PET Validates Higher Rates of Metastatic Disease for European Association of Urology Biochemical Recurrence Risk Groups: An International Multicenter Study

Justin Ferdinandus, Wolfgang P. Fendler, Andrea Farolfi, Samuel Washington, Osama Mohamad, Miguel H. Pampaloni, Peter J.H. Scott, Melissa Rodnick, Benjamin L. Viglianti, Matthias Eiber, Ken Herrmann, Johannes Czernin, Wesley R. Armstrong, Jeremie Calais, Thomas A. Hope, and Morand Piert

Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital Essen, Essen, Germany

J Nucl Med 2022; 63:76–80

 

Response to Combined Peptide Receptor Radionuclide Therapy and Checkpoint Immunotherapy with Ipilimumab Plus Nivolumab in Metastatic Merkel Cell Carcinoma

Justin Ferdinandus, Wolfgang P. Fendler, Katharina Lueckerath, Christoph Berliner, Sabine Kurzidem, Eva Hadaschik, Joachim Klode, Lisa Zimmer, Elisabeth Livingstone, Dirk Schadendorf, Ken Herrmann, Juergen C. Becker, and Selma Ugurel

Department of Nuclear Medicine, University of Duisburg–Essen, and German Cancer Consortium, University Hospital Essen, Essen, Germany

J Nucl Med 2022; 63:396–398

 

Tracking Innate Immune Activation in a Mouse Model of Parkinson’s Disease Using TREM1 and TSPO PET Tracers

Katherine L. Lucot, Marc Y. Stevens, T. Adam Bonham, E. Carmen Azevedo, Aisling M. Chaney, Ebony D. Webber, Poorva Jain, Jessica L. Klockow, Isaac M. Jackson, Mackenzie L. Carlson, Edward E. Graves, Thomas J. Montine, and Michelle L. James

Department of Pathology, Stanford University, Stanford, California

J Nucl Med 2022; 63:1570–1578

 

Dual-Tracer PET/CT Protocol with [¹⁸F]-FDG and [⁶⁸Ga]Ga-FAPI-46 for Cancer Imaging: A Proof of Concept

Katrin S. Roth, Conrad-Amadeus Voltin, Lutz van Heek, Simone Wegen, Klaus Schomäcker, Thomas Fischer, Simone Marnitz, Alexander Drzezga, and Carsten Kobe

Department of Nuclear Medicine, Faculty of Medicine, University Hospital Cologne, University of Cologne, Cologne, Germany

J Nucl Med 2022; 63:1683–1686

 

Glypican-3–Targeted ²²⁷Th α-Therapy Reduces Tumor Burden in an Orthotopic Xenograft Murine Model of Hepatocellular Carcinoma

Kevin P. Labadie, Donald K. Hamlin, Aimee Kenoyer, Sara K. Daniel, Alan F. Utria, Andrew D. Ludwig, Heidi L. Kenerson, Lily Li, Jonathan G. Sham, Delphine L. Chen, Johnnie J. Orozco, Raymond S. Yeung, Chris Orvig, Yawen Li, D. Scott Wilbur, and James O. Park

Department of Surgery, University of Washington, Seattle, Washington

J Nucl Med 2022; 63:1033–1038

 

¹⁸F-FDG PET Maximum-Intensity Projections and Artificial Intelligence: A Win-Win Combination to Easily Measure Prognostic Biomarkers in DLBCL Patients

Kibrom B. Girum, Louis Rebaud, Anne-Ségolène Cottereau, Michel Meignan, Jérôme Clerc, Laetitia Vercellino, Olivier Casasnovas, Franck Morschhauser, Catherine Thieblemont, and Irène Buvat

LITO Laboratory, U1288 Inserm, Institut Curie, University Paris-Saclay, Orsay, France

J Nucl Med 2022; 63:1925–1932

 

¹⁸F-PI-2620 Tau PET Improves the Imaging Diagnosis of Progressive Supranuclear Palsy

Konstantin Messerschmidt, Henryk Barthel, Matthias Brendel, Cordula Scherlach, Karl-Titus Hoffmann, Boris-Stephan Rauchmann, Michael Rullmann, Kenneth Marek, Victor L. Villemagne, Jost-Julian Rumpf, Dorothee Saur, Matthias L. Schroeter, Andreas Schildan, Marianne Patt, Leonie Beyer, Mengmeng Song, Carla Palleis, Sabrina Katzdobler, Urban M. Fietzek, Gesine Respondek, Maximilian Scheifele, Alexander Nitschmann, Christian Zach, Olivier Barret, Jennifer Madonia, David Russell, Andrew W. Stephens, Norman Koglin, Sigrun Roeber, Jochen Herms, Kai Bötzel, Peter Bartenstein, Johannes Levin, John P. Seibyl, Günter Höglinger, Joseph Classen, and Osama Sabri, for the German Imaging Initiative for Tauopathies (GII4T)

Department of Nuclear Medicine, Leipzig University Medical Center, Leipzig, Germany

J Nucl Med 2022; 63:1754–1760

 

Single-Cell Radiotracer Allocation via Immunomagnetic Sorting to Disentangle PET Signals at Cellular Resolution

Laura M. Bartos, Sebastian T. Kunte, Philipp Beumers, Xianyuan Xiang, Karin Wind, Sibylle Ziegler, Peter Bartenstein, Hongyoon Choi, Dong Soo Lee, Christian Haass, Louisa von Baumgarten, Sabina Tahirovic, Nathalie L. Albert, Simon Lindner, and Matthias Brendel

Department of Nuclear Medicine, University Hospital of Munich, LMU Munich, Munich, Germany

J Nucl Med 2022; 63:1459–1462

 

Synthesis, Preclinical Evaluation, and a Pilot Clinical PET Imaging Study of ⁶⁸Ga-Labeled FAPI Dimer

Liang Zhao, Bo Niu, Jianyang Fang, Yizhen Pang, Siyang Li, Chengrong Xie, Long Sun, Xianzhong Zhang, Zhide Guo, Qin Lin, and Haojun Chen

Department of Nuclear Medicine and Minnan PET Center, The First Affiliated Hospital of Xiamen University, Xiamen, China

J Nucl Med 2022; 63:862–868

⁸⁹Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted ²²⁷Th-Conjugate Therapy in Mice

Linda N. Broer, Daan G. Knapen, Frans V. Suurs, Ingrid Moen, Danique Giesen, Stijn J.H. Waaijer, Baard Indrevoll, Christine Ellingsen, Alexander Kristian, Alan S. Cuthbertson, Derk-Jan A. de Groot, Patricia E. Cole, Elisabeth G.E. de Vries, Urs B. Hagemann, and Marjolijn N. Lub-de Hooge

Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands

J Nucl Med 2022; 63:1715–1721

 

Prognostic Value of Urokinase-Type Plasminogen Activator Receptor PET/CT in Head and Neck Squamous Cell Carcinomas and Comparison with ¹⁸F-FDG PET/CT: A Single-Center Prospective Study

Louise M. Risør, Malene M. Clausen, Zaza Ujmajuridze, Mohammed Farhadi, Kim F. Andersen, Annika Loft, Jeppe Friborg, and Andreas Kjaer

Department of Clinical Physiology, Nuclear Medicine, and PET and Cluster for Molecular Imaging, Copenhagen University Hospital–Rigshospitalet, and Department of Biomedical Sciences, University of Copenhagen, Copenhagen, Denmark

J Nucl Med 2022; 63:1169–1176

 

First-in-Humans Brain PET Imaging of the GluN2B-Containing N-methyl-d-aspartate Receptor with (R)-¹¹C-Me-NB1

Lucas Rischka, Chrysoula Vraka, Verena Pichler, Sazan Rasul, Lukas Nics, Gregor Gryglewski, Patricia Handschuh, Matej Murgaš, Godber M. Godbersen, Leo R. Silberbauer, Jakob Unterholzner, Christoph Wotawa, Ahmed Haider, Hazem Ahmed, Roger Schibli, Thomas Mindt, Markus Mitterhauser, Wolfgang Wadsak, Andreas Hahn, Rupert Lanzenberger, Marcus Hacker, and Simon M. Ametamey

Department of Psychiatry and Psychotherapy, Medical University of Vienna, Vienna, Austria

J Nucl Med 2022; 63:936–941

 

Pitfalls and Common Findings in ⁶⁸Ga-FAPI PET: A Pictorial Analysis

Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Fadi Zarrad, Michael Nader, David Kersting, Manuel Weber, Sandra Kazek, Miriam Sraieb, Rainer Hamacher, Katharina Lueckerath, Lale Umutlu, Wolfgang P. Fendler, and Christoph Rischpler

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany

J Nucl Med 2022; 63:890–896

 

⁶⁸Ga-FAPI as a Diagnostic Tool in Sarcoma: Data from the ⁶⁸Ga-FAPI PET Prospective Observational Trial

Lukas Kessler, Justin Ferdinandus, Nader Hirmas, Sebastian Bauer, Uta Dirksen, Fadi Zarrad, Michael Nader, Michal Chodyla, Aleksandar Milosevic, Lale Umutlu, Martin Schuler, Lars Erik Podleska, Hans-Ulrich Schildhaus, Wolfgang P. Fendler, and Rainer Hamacher

Department of Nuclear Medicine, University Hospital Essen, University of Duisburg–Essen, Essen, Germany

J Nucl Med 2022; 63:89–95

 

Fibroblast Activation Protein–Specific PET/CT Imaging in Fibrotic Interstitial Lung Diseases and Lung Cancer: A Translational Exploratory Study

Manuel Röhrich, Dominik Leitz, Frederik M. Glatting, Annika K. Wefers, Oliver Weinheimer, Paul Flechsig, Nicolas Kahn, Marcus A. Mall, Frederik L. Giesel, Clemens Kratochwil, Peter E. Huber, Andreas von Deimling, Claus Peter Heußel, Hans Ulrich Kauczor, Michael Kreuter, and Uwe Haberkorn

Department of Nuclear Medicine, University Hospital Heidelberg, Heidelberg, Germany

J Nucl Med 2022; 63:127–133

 

Diagnostic Performance of ¹²⁴I-Metaiodobenzylguanidine PET/CT in Patients with Pheochromocytoma

Manuel Weber, Jochen Schmitz, Ines Maric, Kim Pabst, Lale Umutlu, Martin Walz, Ken Herrmann, Christoph Rischpler, Frank Weber, Walter Jentzen, Sarah Theurer, Thorsten D. Poeppel, Nicole Unger, and Wolfgang P. Fendler

Department of Nuclear Medicine, University Hospital Essen, Essen, Germany

J Nucl Med 2022; 63:869–874

 

Safety and Efficacy of ¹⁶⁶Ho Radioembolization in Hepatocellular Carcinoma: The HEPAR Primary Study

Margot T.M. Reinders, Karel J. van Erpecum, Maarten L.J. Smits, Arthur J.A.T. Braat, Joep de Bruijne, Rutger Bruijnen, Dave Sprengers, Robert A. de Man, Erik Vegt, Jan N.M. IJzermans, Adriaan Moelker, and Marnix G.E.H. Lam

Department of Radiology and Nuclear Medicine, University Medical Centre, Utrecht University, Utrecht, The Netherlands

J Nucl Med 2022; 63:1891–1898

 

²²³Ra Induces Transient Functional Bone Marrow Toxicity

Maria Parlani, Francesco Boccalatte, Anna Yeaton, Feng Wang, Jianhua Zhang, Iannis Aifantis, and Eleonora Dondossola

Genitourinary Medical Oncology Department and David H. Koch Center for Applied Research of Genitourinary Cancers, University of Texas M.D. Anderson Cancer Center, Houston, Texas

J Nucl Med 2022; 63:1544-1550

 

The Role of Amyloid PET in Imaging Neurodegenerative Disorders: A Review

Marianne Chapleau, Leonardo Iaccarino, David Soleimani-Meigooni, and Gil D. Rabinovici

Memory and Aging Center, Department of Neurology, University of California, San Francisco, San Francisco, California

J Nucl Med 2022; 63(suppl 1):13S–19S

 

Reproducibility of PSMA PET/CT Imaging for Primary Staging of Treatment-Naïve Prostate Cancer Patients Depends on the Applied Radiotracer: A Retrospective Study

Marinus J. Hagens, Daniela E. Oprea-Lager, André N. Vis, Maurits Wondergem, Maarten L. Donswijk, Dennie Meijer, Louise Emmett, Pim J. van Leeuwen, and Henk G. van der Poel

Department of Urology, Netherlands Cancer Institute–Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands

J Nucl Med 2022; 63:1531–1536

 

From Concept to Regulatory Drug Approval: Lessons for Theranostics

Marlon Perera and Michael J. Morris

Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

J Nucl Med 2022; 63:1793–1801

 

Sex Differences and Caffeine Impact in Adenosine-Induced Hyperemia

Martin Lyngby Lassen, Christina Byrne, Majid Sheykhzade, Mads Wissenberg, Preetee Kapisha Hurry, Anne Vibeke Schmedes, Andreas Kjaer, and Philip Hasbak

Department of Clinical Physiology, Nuclear Medicine and PET and Cluster for Molecular Imaging, Rigshospitalet and University of Copenhagen, Copenhagen, Denmark

J Nucl Med 2022; 63:431–437

 

Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts

Maryam Oroujeni, Hanna Tano, Anzhelika Vorobyeva, Yongsheng Liu, Olga Vorontsova, Tianqi Xu, Kristina Westerlund, Anna Orlova, Vladimir Tolmachev, and Amelie Eriksson Karlström

Department of Immunology, Genetics, and Pathology, Uppsala University, Uppsala, Sweden

J Nucl Med 2022; 63:1046–1051

 

First-in-Humans PET Imaging of Tissue Factor in Patients with Primary and Metastatic Cancers Using ¹⁸F-labeled Active-Site Inhibited Factor VII (¹⁸F-ASIS): Potential as Companion Diagnostic

Mathias Loft, Camilla Christensen, Malene M. Clausen, Esben A. Carlsen, Carsten P. Hansen, Niels Kroman, Seppo W. Langer, Claus Høgdall, Jacob Madsen, Nic Gillings, Carsten H. Nielsen, Thomas L. Klausen, Søren Holm, Annika Loft, Anne K. Berthelsen, and Andreas Kjaer

Department of Clinical Physiology and Nuclear Medicine & Cluster for Molecular Imaging, Copenhagen University Hospital – Rigshospitalet & Department of Biomedical Sciences, University of Copenhagen, Denmark

J Nucl Med 2022; 63:1871–1879

 

Pretreatment Levels of Soluble Tumor Necrosis Factor Receptor 1 and Hepatocyte Growth Factor Predict Toxicity and Overall Survival After ⁹⁰Y Radioembolization: Potential Novel Application of Biomarkers for Personalized Management of Hepatotoxicity

Matthew M. Cousins, Theresa P. Devasia, Christopher M. Maurino, Justin Mikell, Matthew J. Schipper, Ravi K. Kaza, Theodore. S. Lawrence, Kyle C. Cuneo, and Yuni K. Dewaraja

Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan

J Nucl Med 2022; 63:882–889

 

In Vivo ¹⁸F-Flortaucipir PET Does Not Accurately Support the Staging of Progressive Supranuclear Palsy

Maura Malpetti, Sanne S. Kaalund, Kamen A. Tsvetanov, Timothy Rittman, Mayen Briggs, Kieren S.J. Allinson, Luca Passamonti, Negin Holland, P. Simon Jones, Tim D. Fryer, Young T. Hong, Antonina Kouli, W. Richard Bevan-Jones, Elijah Mak, George Savulich, Maria Grazia Spillantini, Franklin I. Aigbirhio, Caroline H. Williams-Gray, John T. O’Brien, and James B. Rowe

Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom

J Nucl Med 2022; 63:1052–1057

 

Feasibility of In Vivo Imaging of Fibroblast Activation Protein in Human Arterial Walls

Meiqi Wu, Jing Ning, Jingle Li, Zhichao Lai, Ximin Shi, Haiqun Xing, Marcus Hacker, Bao Liu, Li Huo, and Xiang Li

Department of Nuclear Medicine, State Key Laboratory of Complex Severe and Rare Diseases, Center for Rare Diseases Research, Beijing Key Laboratory of Molecular Targeted Diagnosis and Therapy in Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Science and Peking Union Medical College, Beijing, China

J Nucl Med 2022; 63:948–951

 

Albumin Binder–Conjugated Fibroblast Activation Protein Inhibitor Radiopharmaceuticals for Cancer Therapy

Mengxin Xu, Pu Zhang, Jie Ding, Junyi Chen, Li Huo, and Zhibo Liu

Radiochemistry and Radiation Chemistry Key Laboratory of Fundamental Science, Beijing National Laboratory for Molecular Sciences, College of Chemistry and Molecular Engineering, Peking University, Beijing, China

J Nucl Med 2022; 63:952–958

 

Combined Targeted Radiopharmaceutical Therapy and Immune Checkpoint Blockade: From Preclinical Advances to the Clinic

Michael C. Bellavia, Ravi B. Patel, and Carolyn J. Anderson

Department of Bioengineering, University of Pittsburgh, Pittsburgh, Pennsylvania

J Nucl Med 2022; 63:1636–1641

 

COVID-19 mRNA Vaccination: Age and Immune Status and Its Association with Axillary Lymph Node PET/CT Uptake

Michal Eifer, Noam Tau, Yousef Alhoubani, Nayroz Kanana, Liran Domachevsky, Jala Shams, Nir Keret, Malka Gorfine, and Yael Eshet

Department of Diagnostic Imaging, Chaim Sheba Medical Center, Ramat Gan, Israel

J Nucl Med 2022; 63:134–139

 

Blind Image Restoration Enhances Digital Autoradiographic Imaging of Radiopharmaceutical Tissue Distribution

Lu Peng, Benabdallah Nadia, Jiang Wen, Brian W. Simons, Zhang Hanwen, Robert F. Hobbs, Ulmert David, Brian C. Baumann, Russell K. Pachynski, Abhinav K. Jha, and Daniel L.J. Thorek

Department of Biomedical Engineering, Washington University in St. Louis, St. Louis, Missouri

J Nucl Med 2022; 63:591–597

 

¹⁸F-BMS986192 PET Imaging of PD-L1 in Metastatic Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors: A Pilot Study

Pieter H. Nienhuis, Inês F. Antunes, Andor W.J.M. Glaudemans, Mathilde Jalving, David Leung, Walter Noordzij, Riemer H.J.A. Slart, Erik F.J. de Vries, and Geke A.P. Hospers

Department of Nuclear Medicine and Molecular Imaging, Medical Imaging Center, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

J Nucl Med 2022; 63:899–905

 

⁶⁸Ga-PSMA PET/CT for Response Assessment and Outcome Prediction in Metastatic Prostate Cancer Patients Treated with Taxane-Based Chemotherapy

Qaid Ahmed Shagera, Carlos Artigas, Ioannis Karfis, Gabriela Critchi, Nieves Martinez Chanza, Spyridon Sideris, Alexandre Peltier, Marianne Paesmans, Thierry Gil, and Patrick Flamen

Department of Nuclear Medicine, Institut Jules Bordet, Université Libre de Bruxelles, Brussels, Belgium

J Nucl Med 2022; 63:1191–1198

 

Factors for Differential Outcome Across Cancers in Clinical Molecule-Targeted Fluorescence Imaging

Quan Zhou, Nynke S. van den Berg, Wenying Kang, Jacqueline Pei, Naoki Nishio, Stan van Keulen, Myrthe A. Engelen, Yu-Jin Lee, Marisa Hom, Johana C.M. Vega Leonel, Zachary Hart, Hannes Vogel, Romain Cayrol, Brock A. Martin, Mark Roesner, Glenn Shields, Natalie Lui, Melanie Hayden Gephart, Roan C. Raymundo, Grace Yi, Monica Granucci, Gerald A. Grant, Gordon Li, and Eben L. Rosenthal

Department of Neurosurgery, Stanford University School of Medicine, Stanford, California

J Nucl Med 2022; 63:1693–1700

 

Biodistribution of ¹⁸F-FES in Patients with Metastatic ER+ Breast Cancer Undergoing Treatment with Rintodestrant (G1T48), a Novel Selective ER Degrader

Ramsha Iqbal, Maqsood Yaqub, Daniela E. Oprea-Lager, Yeukman Liu, Anne Marije Luik, Andy P. Beelen, Robert C. Schuit, Albert D. Windhorst, Ronald Boellaard, and Catharina W. Menke-van der Houven van Oordt

Amsterdam UMC, Vrije Universiteit Amsterdam, Medical Oncology, Cancer Center Amsterdam, Amsterdam, Netherlands

J Nucl Med 2022; 63:694–699

 

Repeatability of ⁶⁸Ga-PSMA-HBED-CC PET/CT–Derived Total Molecular Tumor Volume

Robert Seifert, Patrick Sandach, David Kersting, Wolfgang P. Fendler, Boris Hadaschik, Ken Herrmann, John J. Sunderland, and Janet H. Pollard

Department of Nuclear Medicine, University of Duisburg–Essen and German Cancer Consortium–University Hospital, Essen, Germany

J Nucl Med 2022; 63:746–753

 

⁸⁹Zr-DFO-Durvalumab PET/CT Before Durvalumab Treatment in Patients with Recurrent or Metastatic Head and Neck Cancer

Sarah R. Verhoeff, Pim P. van de Donk, Erik H.J.G. Aarntzen, Sjoukje F. Oosting, Adrienne H. Brouwers, Iris H.C. Miedema, Jens Voortman, Willemien C. Menke-van der Houven van Oordt, Ronald Boellaard, Dennis Vriens, Marije Slingerland, Rick Hermsen, Ilse van Engen-van Grunsven, Sandra Heskamp, and Carla M.L. van Herpen

Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands

J Nucl Med 2022; 63:1523–1530

 

Comparison of Exogenous Ketone Administration Versus Dietary Carbohydrate Restriction on Myocardial Glucose Suppression: A Crossover Clinical Trial

Senthil Selvaraj, Kenneth B. Margulies, Supritha Dugyala, Erin Schubert, Ann Tierney, Zoltan Arany, Daniel A. Pryma, Svati H. Shah, J. Eduardo Rame, Daniel P. Kelly, and Paco E. Bravo

Division of Cardiology, Department of Medicine, Perelman School of Medicine of the University of Pennsylvania, Philadelphia, Pennsylvania

J Nucl Med 2022; 63:770–776

 

Safety of Peptide Receptor Radionuclide Therapy with ¹⁷⁷Lu-DOTATATE in Neuroendocrine Tumor Patients with Chronic Kidney Disease

Shahad Alsadik, Gopinath Gnanasegaran, Luohai Chen, Dalvinder Mandair, Christos Toumpanakis, Martyn Caplin, and Shaunak Navalkissoor

Neuroendocrine Unit, Royal Free London NHS Foundation Trust, London, United Kingdom

J Nucl Med 2022; 63:1503–1508

 

¹¹C-PiB and ¹²⁴I-Antibody PET Provide Differing Estimates of Brain Amyloid-β After Therapeutic Intervention

Silvio R. Meier, Dag Sehlin, Sahar Roshanbin, Victoria Lim Falk, Takashi Saito, Takaomi C. Saido, Ulf Neumann, Johanna Rokka, Jonas Eriksson, and Stina Syvänen

Department of Public Health and Caring Sciences/Geriatrics, Uppsala University, Uppsala, Sweden

J Nucl Med 2022; 63:302–309

 

MIRD Pamphlet No. 27: MIRDcell V3, a Revised Software Tool for Multicellular Dosimetry and Bioeffect Modeling

Sumudu Katugampola, Jianchao Wang, Alex Rosen, and Roger W. Howell

Division of Radiation Research, Department of Radiology, New Jersey Medical School, Rutgers University, Newark, New Jersey

J Nucl Med 2022; 63:1441–1449

 

Temporary Reactive Response of Axillary Lymph Nodes to COVID-19 Vaccination on ¹⁸F-rhPSMA-7.3 PET/CT in Patients with Prostate Cancer

Susan Notohamiprodjo, Matthias Eiber, Christian Lohrmann, and Wolfgang A. Weber

Department of Nuclear Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany

J Nucl Med 2022; 63:1673–1676

 

The Influence of Specific Activity on the Biodistribution of ¹⁸F-rhPSMA-7.3: A Retrospective Analysis of Clinical PET Data

Thomas Langbein, Alexander Wurzer, Andrei Gafita, Andrew Robertson, Hui Wang, Ayça Arçay, Michael Herz, Hans-Juergen Wester, Wolfgang A. Weber, and Matthias Eiber

Department of Nuclear Medicine, Klinikum rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany

J Nucl Med 2022; 63:742–745

 

Utility of ¹⁸F-rhPSMA-7.3 PET for Imaging of Primary Prostate Cancer and Preoperative Efficacy in N-Staging of Unfavorable Intermediate- to Very High-Risk Patients Validated by Histopathology

Thomas Langbein, Hui Wang, Isabel Rauscher, Markus Kroenke, Karina Knorr, Alexander Wurzer, Kristina Schwamborn, Tobias Maurer, Thomas Horn, Bernhard Haller, Hans-Jürgen Wester, and Matthias Eiber

Department of Nuclear Medicine, Klinikum Rechts der Isar, School of Medicine, Technical University of Munich, Munich, Germany

J Nucl Med 2022; 63:1334–1342

 

A Guideline for Clinicians Performing Clinical Studies with Fluorescence Imaging

Wido Heeman, Jasper Vonk, Vasilis Ntziachristos, Brian W. Pogue, Rudi A.J.O. Dierckx, Schelto Kruijff, and Gooitzen M. van Dam

University of Groningen, Faculty Campus Fryslân, Leeuwarden, The Netherlands

J Nucl Med 2022; 63:640–645

 

Robot-Assisted Prostate-Specific Membrane Antigen–Radioguided Surgery in Primary Diagnosed Prostate Cancer

William Gondoputro, Matthijs J. Scheltema, Alexander Blazevski, Paul Doan, James E. Thompson, Amer Amin, Bart Geboers, Shikha Agrawal, Amila Siriwardana, Pim J. Van Leeuwen, Matthias N. van Oosterom, Fijs W.B. Van Leeuwen, Louise Emmett, and Phillip D. Stricker

Garvan Institute of Medical Research and Kinghorn Cancer Centre, Darlinghurst, NSW, Australia

J Nucl Med 2022; 63:1659–1664

 

Detecting Fibroblast Activation Proteins in Lymphoma Using ⁶⁸Ga-FAPI PET/CT

Xiao Jin, Maomao Wei, Shuailiang Wang, Guochang Wang, Yumei Lai, Yunfei Shi, Yan Zhang, Zhi Yang, and Xuejuan Wang

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education) and NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Department of Nuclear Medicine, Peking University Cancer Hospital and Institute, Beijing, China

J Nucl Med 2022; 63:212–217

 

First-in-Humans Evaluation of a PD-L1–Binding Peptide PET Radiotracer in Non–Small Cell Lung Cancer Patients

Xin Zhou, Jinquan Jiang, Xue Yang, Teli Liu, Jin Ding, Sridhar Nimmagadda, Martin G. Pomper, Hua Zhu, Jun Zhao, Zhi Yang, and Nan Li

Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Nuclear Medicine, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), Peking University Cancer Hospital & Institute, Beijing, China

J Nucl Med 2022; 63:536–542

 

Feasibility of Acquisitions Using Total-Body PET/CT with an Ultra-Low ¹⁸F-FDG Activity

Yan Hu, Guobing Liu, Haojun Yu, Ying Wang, Chenwei Li, Hui Tan, Shuguang Chen, Jianying Gu, and Hongcheng Shi

Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China

J Nucl Med 2022; 63:959–965

 

¹³¹I-GD2-ch14.18 Scintigraphy to Evaluate Option for Radioimmunotherapy in Patients with Advanced Tumors

Ying Zhang, Juergen Kupferschlaeger, Peter Lang, Gerald Reischl, Rupert J. Handgretinger, Christian la Fougère, and Helmut Dittmann

Department of Nuclear Medicine and Clinical Molecular Imaging, University Hospital Tuebingen, Tuebingen, Germany

J Nucl Med 2022; 63:205–211

 

Independent Prognostic Utility of ¹¹C-Pittsburgh Compound B PET in Patients with Light-Chain Cardiac Amyloidosis

You-Jung Choi, Youngil Koh, Hyun-Jung Lee, In-Chang Hwang, Jun-Bean Park, Yeonyee E. Yoon, Hack-Lyoung Kim, Hyung-Kwan Kim, Yong-Jin Kim, Goo-Yeong Cho, Dae-Won Sohn, Jin-Chul Paeng, and Seung-Pyo Lee

Division of Cardiology, Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea

J Nucl Med 2022; 63:1064–1069

 

First-in-Human Evaluation of ¹⁸F-PF-06445974, a PET Radioligand That Preferentially Labels Phosphodiesterase-4B

Yuichi Wakabayashi, Per Stenkrona, Ryosuke Arakawa, Xuefeng Yan, Maia G. Van Buskirk, Madeline D. Jenkins, Jose A. Montero Santamaria, Kevin P. Maresca, Akihiro Takano, Jeih-San Liow, Thomas A. Chappie, Andrea Varrone, Sangram Nag, Lei Zhang, Zoë A. Hughes, Christopher J. Schmidt, Shawn D. Doran, Andrew Mannes, Paolo Zanotti-Fregonara, Maarten Ooms, Cheryl L. Morse, Sami S. Zoghbi, Christer Halldin, Victor W. Pike, and Robert B. Innis

Molecular Imaging Branch, NIMH-NIH, Bethesda, Maryland

J Nucl Med 2022; 63:1919–1924

SNMMI JNM Best Paper Awards - 

The Journal of Nuclear Medicine

Editors’ Choice Award

FOR THE BEST CLINICAL ARTICLE IN 2022

is presented to

Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling, and Harshad R. Kulkarni

Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany

for

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results

J Nucl Med. 2022; 63:415–423

The Journal of Nuclear Medicine

Editors’ Choice Award

FOR THE BEST BASIC SCIENCE ARTICLE IN 2022

is presented to

Ronnie C. Mease, Choong Mo Kang, Vivek Kumar, Sangeeta Ray Banerjee, Il Minn, Mary Brummet, Kathleen L. Gabrielson, Yutian Feng, Andrew Park, Ana P. Kiess, George Sgouros, Ganesan Vaidyanathan, Michael R. Zalutsky, and Martin G. Pomper

Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, Maryland

for

An Improved ²¹¹At-Labeled Agent for PSMA-Targeted α-Therapy

J Nucl Med. 2022; 63:259–267

The Journal of Nuclear Medicine

Editors’ Choice Award

FOR THE OVERALL BEST ARTICLE IN 2022

is presented to

Richard P. Baum, Christiane Schuchardt, Aviral Singh, Maythinee Chantadisai, Franz C. Robiller, Jingjing Zhang, Dirk Mueller, Alexander Eismant, Frankis Almaguel, Dirk Zboralski, Frank Osterkamp, Aileen Hoehne, Ulrich Reineke, Christiane Smerling, and Harshad R. Kulkarni

Theranostics Center for Molecular Radiotherapy and Molecular Imaging, Zentralklinik Bad Berka, Bad Berka, Germany

for

Feasibility, Biodistribution, and Preliminary Dosimetry in Peptide-Targeted Radionuclide Therapy of Diverse Adenocarcinomas Using ¹⁷⁷Lu-FAP-2286: First-in-Humans Results

J Nucl Med. 2022; 63:415–423

ERF-SNMMI-TS JNMT Best Paper Awards - 

Journal of Nuclear Medicine Technology

Editors’ Choice Award

FOR 1^ST PLACE ARTICLE IN 2022

is presented to

Geoffrey M. Currie, Marko Trifunovic, Jui Liu, Sang Kim, and Howard Gurney

Faculty of Science, Charles Sturt University, Wagga Wagga, Australia

for

¹⁸F-DCFPyL PET/CT in Metastatic Renal Cell Carcinoma

Nucl. Med. Technol. 2022; 50:282–285

Journal of Nuclear Medicine Technology

Editors’ Choice Award

FOR 2^ND PLACE ARTICLE IN 2022

is presented to

Christopher Fecca, Jee Moon, David Posocco, Huaqing Zhao, and Simin Dadparvar

Lewis Katz School of Medicine, Philadelphia, Pennsylvania

for

Accuracy of ¹²³I-Sodium Thyroid Imaging in Calculating Thyroid Volume

Nucl. Med. Technol. 2022; 50:322–326

Journal of Nuclear Medicine Technology

Editors’ Choice Award

FOR 3^RD PLACE ARTICLE IN 2022

is presented to

Dhrumil Naik, Sarah Ternan, Rene Degagne, Wanzhen Zeng, and Ran Klein

Department of Mechanical Engineering, University of Ottawa, Ottawa, Ontario, Canada

for

Thyroid Uptake Exceeding 100%: Causes and Prevention

Nucl. Med. Technol. 2022; 50:153–160

Journal of Nuclear Medicine Technology

Editors’ Choice Award

FOR BEST CONTINUING EDUCATION ARTICLE IN 2022

is presented to

Krystle Glasgow, Mike Dillard, Eric Hertenstein, Allen Justin, Remo George, and Amy Brady

Nuclear Medicine and Molecular Imaging Sciences Program, Department of Clinical and Diagnostic Sciences, School of Health Professions, University of Alabama at Birmingham, Birmingham, Alabama

Going Nuclear with Amino Acids and Proteins: Basic Biochemistry and Molecular Biology Primer for the Technologist

Nucl. Med. Technol. 2022; 50:186–194

Journal of Nuclear Medicine Technology

Editors’ Choice Award

FOR BEST EDUCATORS’ FORUM ARTICLE IN 2022

is presented to

Sarah Frye and Jennifer Prekeges

Saint Louis University, St. Louis, Missouri

for

Interview with Nuclear Medicine Technology Educators on the Impact of COVID-19 on Programs, Outcomes, and Employers

Nucl. Med. Technol. 2022; 50:174–178

Susan C. Weiss Clinical Advancement Scholarship - Ashlee Thomas, CNMT

ERF-SNMMI-TS Bachelor's or Master's Degree Completion Scholarship - Fernando Anleu and Leila Alsarag

ERF-SNMMI-TS Advanced Degree Scholarship - Diane Soulek, CNMT, NCT, PET, RT(N) and Kathryn Beaulieu, BS, CNMT, PET, RT(N)(CT)

Paul Cole Student Technologist Scholarship - Ewelina Bobak, Jennah Knafelc, Lauren Lobner, Chun Kit Ho, Thi "Sammy" Dang, Alexah Sloan, Xavier Hertzner, Jaylee Messmer, Shelby Harmon, Kasey Waldrop

ERF-SNMMI-TS Outstanding Technologist - Joby MacLean, MHA, CNMT

Kathy Thompson Hunt Outstanding Educator Award - Jay Smith, MA, CNMT, RT(R)(N)

2023 Grants and Awards Recipient (funded by the ARRT)

SNMMI-TS Career Advancement Award - Melody Yarbrough, CNMT, RT(N); Kathryn Beaulieu, BS, CNMT, PET, RT(N)(CT); Dylan Shimerda, CNMT; David Kelkis, CNMT, NMTCB(CT); Holly Karsch, CNMT; Nicole Beaulieu, CNMT; Sarah Frye, MBA,CNMT,PET,CCRP

2023 Grants and Awards Recipients (funded by the Nihon Medi-Physics)

2023-2025 Wagner-Torizuka Fellowship Program - Hidenobu Hashimoto, MD, PhD; Yoshiaki Ota, MD, PhD; Yoshikazu Nakano, MD, PhD

2023 Grant Recipients (funded by the SNMMI Value Initiative)

Medical and Science Student Research Grant - Vibha Balaji, Grayson Gimblet, Kelly Trinh, Maliha Imami, Huitian Xia, Kweku Enninful, Abhijit Bhattaru 

2023 Grants and Awards Recipients (funded by the PDEF)

PDEF Mickey Williams Minority Scholarship - Leila Alsarag and Jamaica Dean

PDEF Professional Development Scholarship - Kathryn M. Beaulieu, BS, CNMT, PET, RT(N)(CT)

2023 Council and Center Awards

Saul Hertz Award - Rodney Hicks, MD

Peter E. Valk, MD Memorial Lecuteship Award - Homer Macapinlac, MD, FACNM

GCNMC Lifetime Achievement Award - Alan Maurer, MD, FSNMMI

GCNMC Lectureship Award - Andrew (Tip) Taylor, MD, FACNM, FSNMMI

CIC Barry Siegel Lectureship Award - Michael Graham, PhD, MD, FACR, FSNMMI

Tracey Lynn Faber Award - Qiu Huang

Edward Hoffman Lecture Award - Ronald Boellaard, PhD

Kuhl Lassen Award - Henryk Barthel, PhD

Berson-Yalow Award - Steven Liang, PhD

Hermann Blumgart Award - James Thackeray, PhD

CVC Outstanding Educator Award - Jamie Bourque, MD

AC Tom Miller Memorial Lectureship Award - Twyla Bartel, DO, FACNM, FSNMMI

AC Distinguished Service Award - Erica Cohen Major, DO, MPH, FACN

PIC Conway-Treves Award - Barry Shulkin, MD

Sally W. Schwarz Award - James Ponto, MS, RPh, BCNP